共 164 条
[31]
Xu T(2018)Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls Radiographics 38 200-23
[32]
Zhang YQ(2022)Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy Eur J Nucl Med Mol Imaging 49 1584-undefined
[33]
Hu PC(2021)PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [(177)Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis Eur J Nucl Med Mol Imaging 48 1200-undefined
[34]
Wu RZ(2022)Total Tumor Volume on (18)F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with (225)Ac-PSMA-I&T Biomedicines 10 946-undefined
[35]
Gu YS(1993)Spectral analysis of dynamic PET studies J Cereb Blood Flow Metab 13 15-undefined
[36]
Chen SG(undefined)undefined undefined undefined undefined-undefined
[37]
Yu HJ(undefined)undefined undefined undefined undefined-undefined
[38]
Wen J(undefined)undefined undefined undefined undefined-undefined
[39]
Zhu Y(undefined)undefined undefined undefined undefined-undefined
[40]
Li L(undefined)undefined undefined undefined undefined-undefined